Six-month follow-up of naltrexone and psychotherapy for alcohol dependence

Archives of General Psychiatry

Volumn 53, Issue 3, 1996, Pages 217-224

  O'Malley, Stephanie S ^a   Jaffe, Adam J ^a   Chang, Grace ^b   Rode, Sarah ^a   Schottenfeld, Richard ^a   Meyer, Roger E ^c   Rounsaville, Bruce ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c ASSOCIATION OF AMERICAN MEDICAL COLLEGES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NALTREXONE; RIBOFLAVIN;

ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; ARTICLE; COPING BEHAVIOR; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOTHERAPY; TREATMENT OUTCOME;

EID: 0029926158     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1996.01830030039007     Document Type: Article

References (23)

1. Nicholson RA, Herman JS. Is follow-up necessary in evaluating psychotherapy? Psychol Bull 1980;93:261-278.
2. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville BJ Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry. 1992;49881-887
3. Volpicelli JR. Alterman Al, Hayashida M. Naltrexone in the treatment of alcohol dependence Arch Gen Psychiatry. 1992;49:876-880.
4. O'Malley SS Strategies to maximize the efficacy of naltrexone for alcohol dependence. In: Onken LS, Blame JD, Boren JJ, eds. Potentiating the Efficacy of Medications: Integrating Psychosocial Therapies With Pharmacotherapies in the Treatment of Drug Dependence. Washington, DC: National Institute of Drug Abuse; 1995. Publication NIH 95-3899.
5. Stewart J, de Wit H, Eikelboom R Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol Rev. 1984; 91:251-268.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition Washington, DC: American Psychiatric Association; 1987.
7. Fuller RK, Williford WO, Lee KK, Derman R. Veterans Administration Cooperative Study of Disulfiram in the Treatment of Alcoholism: study design and methodological considerations Control Clin Trials. 1984;5:263-273.
8. Marlatt GA, Gordon JR, eds Relapse Prevention. New York, NY: Guilford Press; 1985.
9. Carroll K, Schottenfeld R. A Therapist's Manual for Relapse Prevention in the Treatment of Alcoholism. New Haven, Conn: Yale University School of Medicine; 1988.
10. Jaffe AJ, Komer P, Witte G, Brown J. Relapse Prevention for the Treatment of Problem Drinking: A Manual for Therapists and Patients. New Haven, Conn: Yale University School of Medicine; Farmmgton: University of Connecticut Health Center; 1989.
11. Sobell MB, Maisto SA, Sobell LC, Cooper AM, Cooper T. Sanders B. Developing a prototype for evaluating alcohol treatment effectiveness. In: Sobell LC, Sobell MB, Ward E. eds. Evaluating Alcohol and Drug Abuse Treatment Effectiveness. Recent Advances. New York, NY: Pergamon Press; 1980;129-150.
12. Sobell LC, Sobell MB. Timeline follow-back: a technique for assessing selfreported ethanol consumption. In: Alien J, Litten R, eds Measuring Alcohol Consumption: Psychosocial and Biochemical Methods. Totowa, NJ. Humana Press lnc, 1992 41-72
13. Spitzer RL, Williams JBW. Structured Clinical Interview for DSM-III-R. New York, NY: Biometrics Research Division, New York State Psychiatric Institute, 1985.
14. Hedeker D, Gibbons RD A random-effects ordinal regression model for multilevel data. Biometrics. 1994;50 933-944.
15. Hedeker D. MIXOR, A Fortran Program for Mixed-Effects Ordinal Probit and Logistic Regression Chicago: University of Illinois at Chicago Prevention Research Center, School of Public Health; 1993.
16. Laird NM, Ware JH Random effects models for longitudinal data. Biometrics. 1982;38:963-974
17. Gibbons RD, Hedeker D, Elkm I, Waternaux C, Kraemer HC, Greenhouse JB, Shea MT, Imber ST, Sotksy SM, Watkins JT. Some conceptual and statistical issues in analyses of longitudinal psychiatric data. Arch Gen Psychiatry. 1993; 50:739-750.
18. Cunningham CL, Okorn DM, Dickinson SD. Naloxone interferes with expression of ethanol-induced conditioned place preference. Alcohol Clin Exp Res 1994;18:518.
19. Annis HM. A cognitive-social learning approach to relapse: pharmacotherapy and relapse prevention counseling. Alcohol Alcohol. 1991;1(suppl 1) 527-530.
20. Peachy JE, Annis HM. New strategies for using the alcohol-sensitizing drugs. In: Naranjo CA, Sellers EM, eds. Recent Advances in New Psychopharmacological Treatments for Alcoholism. Amsterdam, the Netherlands' Elsevier Science Publishers, 1985:199-216.
21. Carroll KM, Rounsaville BJ, Nich C, Gordon LT, Wirtz PW, Gawin F. One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: delayed emergence of psychotherapy effects Arch Gen Psychiatry. 1994,51:989-997.
22. Bohn MJ, Kranzler HR, Beazoglou D, Staehler BA. Nalirexone and brief counseling to reduce heavy drinking, results of a small clinical trial. Am J Addict. 1994;3:91-99.
23. Kazdin RM. Bass E. Power to detect differences between alternate treatments in comparative psychotherapy outcome research. J Consult Clin Psychol 1989, 57 138-147.